295 related articles for article (PubMed ID: 33726650)
21. A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells.
El Hout M; Dos Santos L; Hamaï A; Mehrpour M
Semin Cancer Biol; 2018 Dec; 53():125-138. PubMed ID: 30071257
[TBL] [Abstract][Full Text] [Related]
22. Targeting the metabolism of cancer stem cells by energy disruptor molecules.
Dadgar T; Ebrahimi N; Gholipour AR; Akbari M; Khani L; Ahmadi A; Hamblin MR
Crit Rev Oncol Hematol; 2022 Jan; 169():103545. PubMed ID: 34838705
[TBL] [Abstract][Full Text] [Related]
23. [Lipid Metabolic Reprogramming and Metabolic Stress in Liver Cancer].
Xu Z; Yuan KF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):561-565. PubMed ID: 34323031
[TBL] [Abstract][Full Text] [Related]
24. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
Hu B; Lin JZ; Yang XB; Sang XT
Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
[TBL] [Abstract][Full Text] [Related]
26. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
[TBL] [Abstract][Full Text] [Related]
27. New dawn for cancer cell death: Emerging role of lipid metabolism.
Zhang C; Zhu N; Li H; Gong Y; Gu J; Shi Y; Liao D; Wang W; Dai A; Qin L
Mol Metab; 2022 Sep; 63():101529. PubMed ID: 35714911
[TBL] [Abstract][Full Text] [Related]
28. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
29. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
30. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
Zhao Y; Dong Q; Li J; Zhang K; Qin J; Zhao J; Sun Q; Wang Z; Wartmann T; Jauch KW; Nelson PJ; Qin L; Bruns C
Semin Cancer Biol; 2018 Dec; 53():139-155. PubMed ID: 30081228
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting).
Ghasemi S; Xu S; Nabavi SM; Amirkhani MA; Sureda A; Tejada S; Lorigooini Z
Phytother Res; 2021 Jul; 35(7):3649-3664. PubMed ID: 33619811
[TBL] [Abstract][Full Text] [Related]
32. Abnormal lipid synthesis as a therapeutic target for cancer stem cells.
Wang SY; Hu QC; Wu T; Xia J; Tao XA; Cheng B
World J Stem Cells; 2022 Feb; 14(2):146-162. PubMed ID: 35432735
[TBL] [Abstract][Full Text] [Related]
33. Contribution of cancer stem cells to tumor vasculogenic mimicry.
Yao XH; Ping YF; Bian XW
Protein Cell; 2011 Apr; 2(4):266-72. PubMed ID: 21533771
[TBL] [Abstract][Full Text] [Related]
34. Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy.
Wu Y; Pu X; Wang X; Xu M
Lipids Health Dis; 2024 Feb; 23(1):35. PubMed ID: 38302980
[TBL] [Abstract][Full Text] [Related]
35. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
[TBL] [Abstract][Full Text] [Related]
36. Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells.
Lo Re O; Douet J; Buschbeck M; Fusilli C; Pazienza V; Panebianco C; Castracani CC; Mazza T; Li Volti G; Vinciguerra M
Epigenetics; 2018; 13(8):829-845. PubMed ID: 30165787
[TBL] [Abstract][Full Text] [Related]
37. Metabolic features of cancer stem cells: the emerging role of lipid metabolism.
Mancini R; Noto A; Pisanu ME; De Vitis C; Maugeri-Saccà M; Ciliberto G
Oncogene; 2018 May; 37(18):2367-2378. PubMed ID: 29445137
[TBL] [Abstract][Full Text] [Related]
38. Immune modulation by a cellular network of mesenchymal stem cells and breast cancer cell subsets: Implication for cancer therapy.
Eltoukhy HS; Sinha G; Moore CA; Sandiford OA; Rameshwar P
Cell Immunol; 2018 Apr; 326():33-41. PubMed ID: 28779846
[TBL] [Abstract][Full Text] [Related]
39. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
[TBL] [Abstract][Full Text] [Related]
40. Lipid Metabolism in Cancer Cells.
Zheng M; Wang W; Liu J; Zhang X; Zhang R
Adv Exp Med Biol; 2021; 1316():49-69. PubMed ID: 33740243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
